Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial

Trial Profile

Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jul 2015

At a glance

  • Drugs Carbetocin (Primary) ; Oxytocin (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Acronyms PPH
  • Most Recent Events

    • 01 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 05 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top